CH CRL (R4)
0.9.0 - Draft
CH CRL (R4)
0.9.0 - Draft
This page is part of the CH CRL (R4) (v0.9.0: STU Draft) based on FHIR R4. . For a full list of available versions, see the Directory of published versions 
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="nkrs-iccc3extendedcode"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>This code system http://fhir.ch/ig/ch-crl/CodeSystem/nkrs-iccc3extendedcode defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">Ia.1<a name="nkrs-iccc3extendedcode-Ia.461"> </a></td><td>Precursor cell leukaemias</td></tr><tr><td style="white-space:nowrap">Ia.2<a name="nkrs-iccc3extendedcode-Ia.462"> </a></td><td>Mature B-cell leukaemias</td></tr><tr><td style="white-space:nowrap">Ia.3<a name="nkrs-iccc3extendedcode-Ia.463"> </a></td><td>Mature T-cell and NK cell leukaemias</td></tr><tr><td style="white-space:nowrap">Ia.4<a name="nkrs-iccc3extendedcode-Ia.464"> </a></td><td>Lymphoid leukaemia, NOS</td></tr><tr><td style="white-space:nowrap">IIb.1<a name="nkrs-iccc3extendedcode-IIb.461"> </a></td><td>Precursor cell lymphomas</td></tr><tr><td style="white-space:nowrap">IIb.2<a name="nkrs-iccc3extendedcode-IIb.462"> </a></td><td>Mature B-cell lymphomas (except Burkitt lymphoma)</td></tr><tr><td style="white-space:nowrap">IIb.3<a name="nkrs-iccc3extendedcode-IIb.463"> </a></td><td>Mature T-cell and NK-cell lymphomas</td></tr><tr><td style="white-space:nowrap">IIb.4<a name="nkrs-iccc3extendedcode-IIb.464"> </a></td><td>Non-Hodgkin lymphomas, NOS</td></tr><tr><td style="white-space:nowrap">IIIa.1<a name="nkrs-iccc3extendedcode-IIIa.461"> </a></td><td>Ependymomas</td></tr><tr><td style="white-space:nowrap">IIIa.2<a name="nkrs-iccc3extendedcode-IIIa.462"> </a></td><td>Choroid plexus tumour</td></tr><tr><td style="white-space:nowrap">IIIc.1<a name="nkrs-iccc3extendedcode-IIIc.461"> </a></td><td>Medulloblastomas</td></tr><tr><td style="white-space:nowrap">IIIc.2<a name="nkrs-iccc3extendedcode-IIIc.462"> </a></td><td>PNET</td></tr><tr><td style="white-space:nowrap">IIIc.3<a name="nkrs-iccc3extendedcode-IIIc.463"> </a></td><td>Medulloepithelioma</td></tr><tr><td style="white-space:nowrap">IIIc.4<a name="nkrs-iccc3extendedcode-IIIc.464"> </a></td><td>Atypical teratoid/rhabdoid tumour</td></tr><tr><td style="white-space:nowrap">IIId.1<a name="nkrs-iccc3extendedcode-IIId.461"> </a></td><td>Oligodendrogliomas</td></tr><tr><td style="white-space:nowrap">IIId.2<a name="nkrs-iccc3extendedcode-IIId.462"> </a></td><td>Mixed and unspecified gliomas</td></tr><tr><td style="white-space:nowrap">IIId.3<a name="nkrs-iccc3extendedcode-IIId.463"> </a></td><td>Neuroepithelial glial tumours of uncertain origin</td></tr><tr><td style="white-space:nowrap">IIIe.1<a name="nkrs-iccc3extendedcode-IIIe.461"> </a></td><td>Pituitary adenomas and carcinomas</td></tr><tr><td style="white-space:nowrap">IIIe.2<a name="nkrs-iccc3extendedcode-IIIe.462"> </a></td><td>Tumours of the sellar region (craniopharyngiomas)</td></tr><tr><td style="white-space:nowrap">IIIe.3<a name="nkrs-iccc3extendedcode-IIIe.463"> </a></td><td>Pineal parenchymal tumours</td></tr><tr><td style="white-space:nowrap">IIIe.4<a name="nkrs-iccc3extendedcode-IIIe.464"> </a></td><td>Neuronal and mixed neuronal-glial tumours</td></tr><tr><td style="white-space:nowrap">IIIe.5<a name="nkrs-iccc3extendedcode-IIIe.465"> </a></td><td>Meningiomas</td></tr><tr><td style="white-space:nowrap">VIa.1<a name="nkrs-iccc3extendedcode-VIa.461"> </a></td><td>Nephroblastoma</td></tr><tr><td style="white-space:nowrap">VIa.2<a name="nkrs-iccc3extendedcode-VIa.462"> </a></td><td>Rhabdoid renal tumour</td></tr><tr><td style="white-space:nowrap">VIa.3<a name="nkrs-iccc3extendedcode-VIa.463"> </a></td><td>Kidney sarcomas</td></tr><tr><td style="white-space:nowrap">VIa.4<a name="nkrs-iccc3extendedcode-VIa.464"> </a></td><td>pPNET of kidney</td></tr><tr><td style="white-space:nowrap">VIIIc.1<a name="nkrs-iccc3extendedcode-VIIIc.461"> </a></td><td>Ewing tumour and Askin tumour of bone</td></tr><tr><td style="white-space:nowrap">VIIIc.2<a name="nkrs-iccc3extendedcode-VIIIc.462"> </a></td><td>pPNET of bone</td></tr><tr><td style="white-space:nowrap">VIIId.1<a name="nkrs-iccc3extendedcode-VIIId.461"> </a></td><td>Malignant fibrous neoplasms of bone</td></tr><tr><td style="white-space:nowrap">VIIId.2<a name="nkrs-iccc3extendedcode-VIIId.462"> </a></td><td>Malignant chordomas</td></tr><tr><td style="white-space:nowrap">VIIId.3<a name="nkrs-iccc3extendedcode-VIIId.463"> </a></td><td>Odontogenic malignant tumours</td></tr><tr><td style="white-space:nowrap">VIIId.4<a name="nkrs-iccc3extendedcode-VIIId.464"> </a></td><td>Miscellaneous malignant bone tumours</td></tr><tr><td style="white-space:nowrap">IXb.1<a name="nkrs-iccc3extendedcode-IXb.461"> </a></td><td>Fibroblastic and myofibroblastic tumours</td></tr><tr><td style="white-space:nowrap">IXb.2<a name="nkrs-iccc3extendedcode-IXb.462"> </a></td><td>Nerve sheath tumours</td></tr><tr><td style="white-space:nowrap">IXb.3<a name="nkrs-iccc3extendedcode-IXb.463"> </a></td><td>Other fibromatous neoplasms</td></tr><tr><td style="white-space:nowrap">IXd.1<a name="nkrs-iccc3extendedcode-IXd.461"> </a></td><td>Ewing tumour and Askin tumour of soft tissue</td></tr><tr><td style="white-space:nowrap">IXd.2<a name="nkrs-iccc3extendedcode-IXd.462"> </a></td><td>pPNET of soft tissue</td></tr><tr><td style="white-space:nowrap">IXd.3<a name="nkrs-iccc3extendedcode-IXd.463"> </a></td><td>Extrarenal rhabdoid tumour</td></tr><tr><td style="white-space:nowrap">IXd.4<a name="nkrs-iccc3extendedcode-IXd.464"> </a></td><td>Liposarcomas</td></tr><tr><td style="white-space:nowrap">IXd.5<a name="nkrs-iccc3extendedcode-IXd.465"> </a></td><td>Fibrohistiocytic tumours</td></tr><tr><td style="white-space:nowrap">IXd.6<a name="nkrs-iccc3extendedcode-IXd.466"> </a></td><td>Leiomyosarcomas</td></tr><tr><td style="white-space:nowrap">IXd.7<a name="nkrs-iccc3extendedcode-IXd.467"> </a></td><td>Synovial sarcomas</td></tr><tr><td style="white-space:nowrap">IXd.8<a name="nkrs-iccc3extendedcode-IXd.468"> </a></td><td>Blood vessel tumours</td></tr><tr><td style="white-space:nowrap">IXd.9<a name="nkrs-iccc3extendedcode-IXd.469"> </a></td><td>Osseous and chondromatous neoplasms of soft tissue</td></tr><tr><td style="white-space:nowrap">IXd.10<a name="nkrs-iccc3extendedcode-IXd.4610"> </a></td><td>Alveolar soft parts sarcoma</td></tr><tr><td style="white-space:nowrap">IXd.11<a name="nkrs-iccc3extendedcode-IXd.4611"> </a></td><td>Miscellaneous soft tissue sarcomas</td></tr><tr><td style="white-space:nowrap">Xa.1<a name="nkrs-iccc3extendedcode-Xa.461"> </a></td><td>Intracranial and intraspinal germinomas</td></tr><tr><td style="white-space:nowrap">Xa.2<a name="nkrs-iccc3extendedcode-Xa.462"> </a></td><td>Intracranial and intraspinal teratomas</td></tr><tr><td style="white-space:nowrap">Xa.3<a name="nkrs-iccc3extendedcode-Xa.463"> </a></td><td>Intracranial and intraspinal embryonal carcinomas</td></tr><tr><td style="white-space:nowrap">Xa.4<a name="nkrs-iccc3extendedcode-Xa.464"> </a></td><td>Intracranial and intraspinal yolk sac tumour</td></tr><tr><td style="white-space:nowrap">Xa.5<a name="nkrs-iccc3extendedcode-Xa.465"> </a></td><td>Intracranial and intraspinal choriocarcinoma</td></tr><tr><td style="white-space:nowrap">Xa.6<a name="nkrs-iccc3extendedcode-Xa.466"> </a></td><td>Intracranial and intraspinal tumours of mixed forms</td></tr><tr><td style="white-space:nowrap">Xb.1<a name="nkrs-iccc3extendedcode-Xb.461"> </a></td><td>Malignant germinomas of extracranial and extragonadal sites</td></tr><tr><td style="white-space:nowrap">Xb.2<a name="nkrs-iccc3extendedcode-Xb.462"> </a></td><td>Malignant teratomas of extracranial and extragonadal sites</td></tr><tr><td style="white-space:nowrap">Xb.3<a name="nkrs-iccc3extendedcode-Xb.463"> </a></td><td>Embryonal carcinomas of extracranial and extragonadal sites</td></tr><tr><td style="white-space:nowrap">Xb.4<a name="nkrs-iccc3extendedcode-Xb.464"> </a></td><td>Yolk sac tumour of extracranial and extragonadal sites</td></tr><tr><td style="white-space:nowrap">Xb.5<a name="nkrs-iccc3extendedcode-Xb.465"> </a></td><td>Choriocarcinomas of extracranial and extragonadal sites</td></tr><tr><td style="white-space:nowrap">Xb.6<a name="nkrs-iccc3extendedcode-Xb.466"> </a></td><td>Other and unspecified malignant mixed germ cell tumors of extracranial and extragonadal sites</td></tr><tr><td style="white-space:nowrap">Xc.1<a name="nkrs-iccc3extendedcode-Xc.461"> </a></td><td>Malignant gonadal germinomas</td></tr><tr><td style="white-space:nowrap">Xc.2<a name="nkrs-iccc3extendedcode-Xc.462"> </a></td><td>Malignant gonadal teratomas</td></tr><tr><td style="white-space:nowrap">Xc.3<a name="nkrs-iccc3extendedcode-Xc.463"> </a></td><td>Gonadal embryonal carcinomas</td></tr><tr><td style="white-space:nowrap">Xc.4<a name="nkrs-iccc3extendedcode-Xc.464"> </a></td><td>Gonadal yolk sac tumour</td></tr><tr><td style="white-space:nowrap">Xc.5<a name="nkrs-iccc3extendedcode-Xc.465"> </a></td><td>Gonadal choriocarcinoma</td></tr><tr><td style="white-space:nowrap">Xc.6<a name="nkrs-iccc3extendedcode-Xc.466"> </a></td><td>Malignant gonadal tumours of mixed forms</td></tr><tr><td style="white-space:nowrap">Xc.7<a name="nkrs-iccc3extendedcode-Xc.467"> </a></td><td>Malignant gonadal gonadoblastoma</td></tr><tr><td style="white-space:nowrap">XIf.1<a name="nkrs-iccc3extendedcode-XIf.461"> </a></td><td>Carcinomas of salivary glands</td></tr><tr><td style="white-space:nowrap">XIf.2<a name="nkrs-iccc3extendedcode-XIf.462"> </a></td><td>Carcinomas of colon and rectum</td></tr><tr><td style="white-space:nowrap">XIf.3<a name="nkrs-iccc3extendedcode-XIf.463"> </a></td><td>Carcinomas of appendix</td></tr><tr><td style="white-space:nowrap">XIf.4<a name="nkrs-iccc3extendedcode-XIf.464"> </a></td><td>Carcinomas of lung</td></tr><tr><td style="white-space:nowrap">XIf.5<a name="nkrs-iccc3extendedcode-XIf.465"> </a></td><td>Carcinomas of thymus</td></tr><tr><td style="white-space:nowrap">XIf.6<a name="nkrs-iccc3extendedcode-XIf.466"> </a></td><td>Carcinomas of breast</td></tr><tr><td style="white-space:nowrap">XIf.7<a name="nkrs-iccc3extendedcode-XIf.467"> </a></td><td>Carcinomas of cervix uteri</td></tr><tr><td style="white-space:nowrap">XIf.8<a name="nkrs-iccc3extendedcode-XIf.468"> </a></td><td>Carcinomas of bladder</td></tr><tr><td style="white-space:nowrap">XIf.9<a name="nkrs-iccc3extendedcode-XIf.469"> </a></td><td>Carcinomas of eye</td></tr><tr><td style="white-space:nowrap">XIf.10<a name="nkrs-iccc3extendedcode-XIf.4610"> </a></td><td>Carcinomas of other specified sites</td></tr><tr><td style="white-space:nowrap">XIf.11<a name="nkrs-iccc3extendedcode-XIf.4611"> </a></td><td>Carcinomas of unspecified site</td></tr><tr><td style="white-space:nowrap">XIIa.1<a name="nkrs-iccc3extendedcode-XIIa.461"> </a></td><td>Gastrointestinal stromal tumour</td></tr><tr><td style="white-space:nowrap">XIIa.2<a name="nkrs-iccc3extendedcode-XIIa.462"> </a></td><td>Pancreatoblastoma</td></tr><tr><td style="white-space:nowrap">XIIa.3<a name="nkrs-iccc3extendedcode-XIIa.463"> </a></td><td>Pulmonary blastoma and pleuropulmonary blastoma</td></tr><tr><td style="white-space:nowrap">XIIa.4<a name="nkrs-iccc3extendedcode-XIIa.464"> </a></td><td>Other complex mixed and stromal neoplasms</td></tr><tr><td style="white-space:nowrap">XIIa.5<a name="nkrs-iccc3extendedcode-XIIa.465"> </a></td><td>Mesothelioma</td></tr><tr><td style="white-space:nowrap">XIIa.6<a name="nkrs-iccc3extendedcode-XIIa.466"> </a></td><td>Other specified malignant tumours</td></tr></table></div>
</text>
<url value="http://fhir.ch/ig/ch-crl/CodeSystem/nkrs-iccc3extendedcode"/>
<version value="0.9.0"/>
<name value="NkrsICCC3ExtendedCode"/>
<title value="NKRS - ICCC-3 Extended Code"/>
<status value="active"/>
<date value="2022-02-04T14:14:21+01:00"/>
<publisher value="Bundesamt für Gesundheit BAG"/>
<contact>
<name value="Bundesamt für Gesundheit BAG"/>
<telecom>
<system value="url"/>
<value value="https://www.bag.admin.ch/"/>
</telecom>
</contact>
<description
value="This data item records detailed division of the diagnostic group according to the third revision
of the 1996 International Classification of Childhood Cancer (ICCC-3).
**ICCC-3 code (Variable number: 3.9.3)**
in \'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)\'
([EN](https://www.nacr.ch/assets/files/uploads/a-datadictionary-basicvariables-v1.1.pdf),
[DE](https://www.nkrs.ch/assets/files/uploads/a-datenstruktur-variablen-der-basisdaten-v1.1.pdf),
[FR](https://www.onec.ch/assets/files/uploads/a-dict-des-donnees-variables-de-base-v1.1.pdf),
[IT](https://www.snrt.ch/assets/files/uploads/a-dati-oncologici-variabili-di-base-v1.1.pdf))"/>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="CH"/>
</coding>
</jurisdiction>
<copyright value="CC-BY-SA-4.0"/>
<caseSensitive value="true"/>
<valueSet value="http://fhir.ch/ig/ch-crl/ValueSet/nkrs-iccc3extendedcode"/>
<content value="complete"/>
<count value="82"/>
<concept>
<code value="Ia.1"/>
<display value="Precursor cell leukaemias"/>
</concept>
<concept>
<code value="Ia.2"/>
<display value="Mature B-cell leukaemias"/>
</concept>
<concept>
<code value="Ia.3"/>
<display value="Mature T-cell and NK cell leukaemias"/>
</concept>
<concept>
<code value="Ia.4"/>
<display value="Lymphoid leukaemia, NOS"/>
</concept>
<concept>
<code value="IIb.1"/>
<display value="Precursor cell lymphomas"/>
</concept>
<concept>
<code value="IIb.2"/>
<display value="Mature B-cell lymphomas (except Burkitt lymphoma)"/>
</concept>
<concept>
<code value="IIb.3"/>
<display value="Mature T-cell and NK-cell lymphomas"/>
</concept>
<concept>
<code value="IIb.4"/>
<display value="Non-Hodgkin lymphomas, NOS"/>
</concept>
<concept>
<code value="IIIa.1"/>
<display value="Ependymomas"/>
</concept>
<concept>
<code value="IIIa.2"/>
<display value="Choroid plexus tumour"/>
</concept>
<concept>
<code value="IIIc.1"/>
<display value="Medulloblastomas"/>
</concept>
<concept>
<code value="IIIc.2"/>
<display value="PNET"/>
</concept>
<concept>
<code value="IIIc.3"/>
<display value="Medulloepithelioma"/>
</concept>
<concept>
<code value="IIIc.4"/>
<display value="Atypical teratoid/rhabdoid tumour"/>
</concept>
<concept>
<code value="IIId.1"/>
<display value="Oligodendrogliomas"/>
</concept>
<concept>
<code value="IIId.2"/>
<display value="Mixed and unspecified gliomas"/>
</concept>
<concept>
<code value="IIId.3"/>
<display value="Neuroepithelial glial tumours of uncertain origin"/>
</concept>
<concept>
<code value="IIIe.1"/>
<display value="Pituitary adenomas and carcinomas"/>
</concept>
<concept>
<code value="IIIe.2"/>
<display value="Tumours of the sellar region (craniopharyngiomas)"/>
</concept>
<concept>
<code value="IIIe.3"/>
<display value="Pineal parenchymal tumours"/>
</concept>
<concept>
<code value="IIIe.4"/>
<display value="Neuronal and mixed neuronal-glial tumours"/>
</concept>
<concept>
<code value="IIIe.5"/>
<display value="Meningiomas"/>
</concept>
<concept>
<code value="VIa.1"/>
<display value="Nephroblastoma"/>
</concept>
<concept>
<code value="VIa.2"/>
<display value="Rhabdoid renal tumour"/>
</concept>
<concept>
<code value="VIa.3"/>
<display value="Kidney sarcomas"/>
</concept>
<concept>
<code value="VIa.4"/>
<display value="pPNET of kidney"/>
</concept>
<concept>
<code value="VIIIc.1"/>
<display value="Ewing tumour and Askin tumour of bone"/>
</concept>
<concept>
<code value="VIIIc.2"/>
<display value="pPNET of bone"/>
</concept>
<concept>
<code value="VIIId.1"/>
<display value="Malignant fibrous neoplasms of bone"/>
</concept>
<concept>
<code value="VIIId.2"/>
<display value="Malignant chordomas"/>
</concept>
<concept>
<code value="VIIId.3"/>
<display value="Odontogenic malignant tumours"/>
</concept>
<concept>
<code value="VIIId.4"/>
<display value="Miscellaneous malignant bone tumours"/>
</concept>
<concept>
<code value="IXb.1"/>
<display value="Fibroblastic and myofibroblastic tumours"/>
</concept>
<concept>
<code value="IXb.2"/>
<display value="Nerve sheath tumours"/>
</concept>
<concept>
<code value="IXb.3"/>
<display value="Other fibromatous neoplasms"/>
</concept>
<concept>
<code value="IXd.1"/>
<display value="Ewing tumour and Askin tumour of soft tissue"/>
</concept>
<concept>
<code value="IXd.2"/>
<display value="pPNET of soft tissue"/>
</concept>
<concept>
<code value="IXd.3"/>
<display value="Extrarenal rhabdoid tumour"/>
</concept>
<concept>
<code value="IXd.4"/>
<display value="Liposarcomas"/>
</concept>
<concept>
<code value="IXd.5"/>
<display value="Fibrohistiocytic tumours"/>
</concept>
<concept>
<code value="IXd.6"/>
<display value="Leiomyosarcomas"/>
</concept>
<concept>
<code value="IXd.7"/>
<display value="Synovial sarcomas"/>
</concept>
<concept>
<code value="IXd.8"/>
<display value="Blood vessel tumours"/>
</concept>
<concept>
<code value="IXd.9"/>
<display value="Osseous and chondromatous neoplasms of soft tissue"/>
</concept>
<concept>
<code value="IXd.10"/>
<display value="Alveolar soft parts sarcoma"/>
</concept>
<concept>
<code value="IXd.11"/>
<display value="Miscellaneous soft tissue sarcomas"/>
</concept>
<concept>
<code value="Xa.1"/>
<display value="Intracranial and intraspinal germinomas"/>
</concept>
<concept>
<code value="Xa.2"/>
<display value="Intracranial and intraspinal teratomas"/>
</concept>
<concept>
<code value="Xa.3"/>
<display value="Intracranial and intraspinal embryonal carcinomas"/>
</concept>
<concept>
<code value="Xa.4"/>
<display value="Intracranial and intraspinal yolk sac tumour"/>
</concept>
<concept>
<code value="Xa.5"/>
<display value="Intracranial and intraspinal choriocarcinoma"/>
</concept>
<concept>
<code value="Xa.6"/>
<display value="Intracranial and intraspinal tumours of mixed forms"/>
</concept>
<concept>
<code value="Xb.1"/>
<display value="Malignant germinomas of extracranial and extragonadal sites"/>
</concept>
<concept>
<code value="Xb.2"/>
<display value="Malignant teratomas of extracranial and extragonadal sites"/>
</concept>
<concept>
<code value="Xb.3"/>
<display value="Embryonal carcinomas of extracranial and extragonadal sites"/>
</concept>
<concept>
<code value="Xb.4"/>
<display value="Yolk sac tumour of extracranial and extragonadal sites"/>
</concept>
<concept>
<code value="Xb.5"/>
<display value="Choriocarcinomas of extracranial and extragonadal sites"/>
</concept>
<concept>
<code value="Xb.6"/>
<display
value="Other and unspecified malignant mixed germ cell tumors of extracranial and extragonadal sites"/>
</concept>
<concept>
<code value="Xc.1"/>
<display value="Malignant gonadal germinomas"/>
</concept>
<concept>
<code value="Xc.2"/>
<display value="Malignant gonadal teratomas"/>
</concept>
<concept>
<code value="Xc.3"/>
<display value="Gonadal embryonal carcinomas"/>
</concept>
<concept>
<code value="Xc.4"/>
<display value="Gonadal yolk sac tumour"/>
</concept>
<concept>
<code value="Xc.5"/>
<display value="Gonadal choriocarcinoma"/>
</concept>
<concept>
<code value="Xc.6"/>
<display value="Malignant gonadal tumours of mixed forms"/>
</concept>
<concept>
<code value="Xc.7"/>
<display value="Malignant gonadal gonadoblastoma"/>
</concept>
<concept>
<code value="XIf.1"/>
<display value="Carcinomas of salivary glands"/>
</concept>
<concept>
<code value="XIf.2"/>
<display value="Carcinomas of colon and rectum"/>
</concept>
<concept>
<code value="XIf.3"/>
<display value="Carcinomas of appendix"/>
</concept>
<concept>
<code value="XIf.4"/>
<display value="Carcinomas of lung"/>
</concept>
<concept>
<code value="XIf.5"/>
<display value="Carcinomas of thymus"/>
</concept>
<concept>
<code value="XIf.6"/>
<display value="Carcinomas of breast"/>
</concept>
<concept>
<code value="XIf.7"/>
<display value="Carcinomas of cervix uteri"/>
</concept>
<concept>
<code value="XIf.8"/>
<display value="Carcinomas of bladder"/>
</concept>
<concept>
<code value="XIf.9"/>
<display value="Carcinomas of eye"/>
</concept>
<concept>
<code value="XIf.10"/>
<display value="Carcinomas of other specified sites"/>
</concept>
<concept>
<code value="XIf.11"/>
<display value="Carcinomas of unspecified site"/>
</concept>
<concept>
<code value="XIIa.1"/>
<display value="Gastrointestinal stromal tumour"/>
</concept>
<concept>
<code value="XIIa.2"/>
<display value="Pancreatoblastoma"/>
</concept>
<concept>
<code value="XIIa.3"/>
<display value="Pulmonary blastoma and pleuropulmonary blastoma"/>
</concept>
<concept>
<code value="XIIa.4"/>
<display value="Other complex mixed and stromal neoplasms"/>
</concept>
<concept>
<code value="XIIa.5"/>
<display value="Mesothelioma"/>
</concept>
<concept>
<code value="XIIa.6"/>
<display value="Other specified malignant tumours"/>
</concept>
</CodeSystem>